L( )-Aminobernsteinsaeure en es it fr

L( )-Aminobernsteinsaeure Brand names, L( )-Aminobernsteinsaeure Analogs

L( )-Aminobernsteinsaeure Brand Names Mixture

  • No information avaliable

L( )-Aminobernsteinsaeure Chemical_Formula


L( )-Aminobernsteinsaeure RX_link

No information avaliable

L( )-Aminobernsteinsaeure fda sheet

L( )-Aminobernsteinsaeure msds (material safety sheet)


L( )-Aminobernsteinsaeure Synthesis Reference

No information avaliable

L( )-Aminobernsteinsaeure Molecular Weight

133.104 g/mol

L( )-Aminobernsteinsaeure Melting Point

230 oC

L( )-Aminobernsteinsaeure H2O Solubility

4.5 g/l

L( )-Aminobernsteinsaeure State


L( )-Aminobernsteinsaeure LogP

-0.67 +/- 0.36

L( )-Aminobernsteinsaeure Dosage Forms

Capsules and powder

L( )-Aminobernsteinsaeure Indication

There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.

L( )-Aminobernsteinsaeure Pharmacology

L-aspartate is considered a non-essential amino acid, meaning that, under normal physiological conditions, sufficient amounts of the amino acid are synthesized in the body to meet the body's requirements. L-aspartate is formed by the transamination of the Krebs cycle intermediate oxaloacetate. The amino acid serves as a precursor for synthesis of proteins, oligopeptides, purines, pyrimidines, nucleic acids and L-arginine. L-aspartate is a glycogenic amino acid, and it can also promote energy production via its metabolism in the Krebs cycle. These latter activities were the rationale for the claim that supplemental aspartate has an anti-fatigue effect on skeletal muscle, a claim that was never confirmed.

L( )-Aminobernsteinsaeure Absorption

Absorbed from the small intestine by an active transport process

L( )-Aminobernsteinsaeure side effects and Toxicity

Mild gastrointestinal side effects including diarrhea. LD50 (rat) > 5,000 mg/kg.

L( )-Aminobernsteinsaeure Patient Information

No information avaliable

L( )-Aminobernsteinsaeure Organisms Affected

Humans and other mammals